Navigation Links
New clinical prediction index to help patients considering kidney transplant
Date:3/29/2010

A new clinical prediction index has been developed to determine the risk of death in patients with end-stage kidney disease considering transplantation, states a Research article in CMAJ (Canadian Medical Association Journal) (pre-embargo link only) http://www.cmaj.ca/embargo/cmaj091661.pdf.

The article reports on a study aimed at developing and testing a new index that can calculate survival for various options a patient faces with end-stage kidney disease. It included patients on the kidney transplant wait list between 1995 and October 2006 as well as those who had a kidney transplant as their first therapy during the same time.

The index uses readily available data so it can be used in clinics during transplantation counseling. It has a simple scoring system to calculate survival without transplant, with deceased donor transplantation and with living donor transplantation. The goal is to improve decision making by patients and physicians by providing calculated survival information at the time of transplant counseling.

Kidney transplantation is the optimal choice for people with end-stage kidney disease because it improves quality of life and survival rates. Overall, kidney transplant recipients have a 68% lower risk of death than those eligible for transplantation that remained on dialysis. While the benefits of transplantation are significant, there is a need to look at other factors before proceeding including quality of life after transplantation, immunosuppressive medication side effects, malignancy risk, and the need for an extensive medical evaluation or ongoing re-evaluation.

Dr. Carl van Walraven, and coauthors conclude that this prognostic index can accurately to predict mortality among patients with end stage renal disease eligible for transplantation. "We believe that this renal prognostic index can provide valuable quantitative survival data for clinicians and patients to use when deciding on whether to pursue transplantation or remain on dialysis."


'/>"/>

Contact: Kim Barnhardt
kim.barnhardt@cmaj.ca
613-520-7116 x2224
Canadian Medical Association Journal
Source:Eurekalert

Related medicine news :

1. Kineta Awarded NIH Grant to Complete Preclinical Studies on Type 1 Diabetes / Multiple Sclerosis Drug Candidate
2. Childhood cancer patients enrolled in clinical trials need clearer communication about their role
3. Medical schools partner to tackle barriers to minority participation in cancer clinical trials
4. Carefx to Provide Clinical Workflow Solutions for Military Health System
5. The Indiana Clinical and Translational Science Institute (CTSI) Licenses GeneGos Eureka and MetaCore Platforms
6. Metagenics Launches Estrovera™, an All-Natural, Clinically Demonstrated Alternative to Hormone Therapy for Relief of Hot Flashes and Other Menopausal Symptoms*
7. Wound Management Technologies, Inc. Announces Conference Plans and Clinical Data Presentation at Leading Diabetic Foot Conference
8. Novel stroke treatment passes safety stage of UCI-led clinical trial
9. 2010 Recipient of Minority Scholar Award Will Conduct Clinical Research on Leukemia
10. 2010 recipient of Minority Scholar Award will conduct clinical research on leukemia
11. Parrish Medical Center Sees 30 Percent Improvement in Mortality Using Real-Time Clinical Surveillance Solution from Thomson Reuters
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... Ellevate Network, the leading network for professional ... action towards gender equality at their inaugural Summit in New York City in June. ... a social audience of over 3 million. To watch the Mobilize Women video, ...
(Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the Mountains to the Mission ... lost souls in the Philippines. “The Journey: From the Mountains to the Mission Field” ... the Bible. She has taught all ages and currently teaches a class of ladies ...
(Date:10/12/2017)... WAUSAU, Wis. (PRWEB) , ... October 12, 2017 ... ... formulated standard products to meet the demand of today’s consumer and regulatory authorities ... team of probiotic experts and tested to meet the highest standard. , ...
(Date:10/12/2017)... ... October 12, 2017 , ... Dr. Parsa Mohebi, ... a medical article to the newly revamped Cosmetic Town journal section, ... hair transplant procedure known as Follicular Unit Extraction (FUE). , Dr. ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... the nation's first interactive health literacy software tool, and the Cancer Patient Education ... of cancer patient education, today announce a new strategic alliance. , As ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... 2, 2017 The Rebound mobile app is poised ... reverse the tide of prescription drug addiction. The app empowers ... intake and stepping down their dosage in a safe, controlled ... December 2017; the first 100,000 people to sign up will ... http://www.rebound-solution.com/ ...
(Date:9/27/2017)... 27, 2017  Commended for their devotion to personalized service, ... as number one in the South Florida Business Journal,s 50 ... 5000 yearly list, the national specialty pharmacy has found its ... will soon be honored by SFBJ as the 2017 ... Set to receive his award in October, Bardisa said ...
(Date:9/25/2017)...  EpiVax, Inc., a leader in the fields ... announced the launch of EpiVax Oncology Inc., a ... cancer vaccines. EpiVax has provided $500,000 in seed ... technologies to the new precision immunotherapy venture. Gad ... as Chief Executive Officer. Gad brings over 25 ...
Breaking Medicine Technology: